Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Edara, S.
Right arrow Articles by Pegg, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Edara, S.
Right arrow Articles by Pegg, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1999 Oxford University Press

Article

Expression of the inactive C145A mutant human O6-alkylguanine-DNA alkyltransferase in E.coli increases cell killing and mutations by N-methyl-N'-nitro-N-nitrosoguanidine

Suvarchala Edara, Sreenivas Kanugula and Anthony E. Pegg1

Department of Cellular and Molecular Physiology, Milton S. Hershey Medical Center, Pennsylvania State University College of Medicine, Hershey, PA 17033, USA

Human O6-alkylguanine-DNA alkyltransferase (AGT) counteracts the mutagenic and toxic effects of methylating agents such as N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) by removing the methyl group from O6-methylguanine lesions in DNA. The methyl group is transferred to a cysteine acceptor residue in the AGT protein, which is located at residue 145. The C145A mutant of AGT in which this cysteine is converted to an alanine residue is therefore inactive. When this C145A mutant was expressed in an Escherichia coli strain lacking endogenous alkyltransferase activity, the number of G:C->A:T mutations actually increased and the toxicity of the MNNG treatment was enhanced. These effects were not seen when an E.coli strain also lacking nucleotide excision repair (NER) was used. The enhancement of mutagenesis and toxicity of MNNG produced by the C145A mutant AGT was not seen with another inactive mutant Y114E that contains a mutation preventing DNA binding, and the double mutant C145A/Y114E was also ineffective. These results suggest that the C145A mutant AGT binds to O6-methylguanine lesions in DNA and prevents their repair by NER. The inactive C145A mutant AGT also increased the number of A:T->G:C transition mutations in MNNG-treated cells. These mutations are likely to arise from the minor methylation product, O4-methylthymine. However, expression of wild-type AGT also increased the incidence of these mutations. These results support the hypothesis that mammalian AGTs bind to O4-methylthymine but repair the lesion so slowly that they effectively shield it from more efficient repair by NER.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J BiochemHome page
R. Morita, N. Nakagawa, S. Kuramitsu, and R. Masui
An O6-methylguanine-DNA Methyltransferase-like Protein from Thermus thermophilus Interacts with a Nucleotide Excision Repair Protein
J. Biochem., August 1, 2008; 144(2): 267 - 277.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. J. Pearson, J. Ferguson, M. Santibanez-Koref, and G. P. Margison
Inhibition of O6-methylguanine-DNA methyltransferase by an alkyltransferase-like protein from Escherichia coli
Nucleic Acids Res., July 13, 2005; 33(12): 3837 - 3844.
[Abstract] [Full Text] [PDF]


Home page
Neuro Oncol DukeHome page
B. R. Rood, H. Zhang, and P. H. Cogen
Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma
Neuro-oncol, July 1, 2004; 6(3): 200 - 207.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. Liu, A. E. Pegg, K. M. Williams, and F. P. Guengerich
Paradoxical Enhancement of the Toxicity of 1,2-Dibromoethane by O6-Alkylguanine-DNA Alkyltransferase
J. Biol. Chem., September 27, 2002; 277(40): 37920 - 37928.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Xu-Welliver and A. E. Pegg
Degradation of the alkylated form of the DNA repair protein, O6-alkylguanine-DNA alkyltransferase
Carcinogenesis, May 1, 2002; 23(5): 823 - 830.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L. P. Encell and L. A. Loeb
Enhanced in vivo repair of O4-methylthymine by a mutant human DNA alkyltransferase
Carcinogenesis, July 1, 2000; 21(7): 1397 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. B. Kaur, J. M. Travaline, J. P. Gaughan, J. P. Richie Jr., S. D. Stellman, and P. Lazarus
Role of Polymorphisms in Codons 143 and 160 of the O6-Alkylguanine DNA Alkyltransferase Gene in Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 339 - 342.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.